NNBP

Nanobac Pharmaceuticals, Incorporated NNBP

NNBP
Nanobac Pharmaceuticals, Incorporated VPRO
Viropro Inc. MCRT
Microart Inc. CLABF
Core One Labs Inc. HAVLF
HAVN Life Sciences Inc. KLDO
Kaleido Biosciences, Inc. AZFL
Amazonas Florestal, Ltd ONPH
Oncology Pharma Inc. CBDX
Curative Biosciences, Inc. ENDV
Endonovo Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NNBP VPRO MCRT CLABF HAVLF KLDO AZFL ONPH CBDX ENDV
6M 0.00 % -80.00 % 0.00 % -99.83 % -90.00 % 400.00 % 9 900.00 % 600.00 % 0.00 % -66.67 %
YTD 0.00 % -80.00 % 0.00 % -99.83 % -90.00 % 400.00 % 9 900.00 % 600.00 % 0.00 % -85.71 %
1Y 0.00 % -80.00 % 0.00 % -99.90 % 0.00 % 400.00 % 9 900.00 % 69 900.00 % 0.00 % -88.89 %
3Y 0.00 % -80.00 % 1 900.00 % -99.98 % -99.81 % -54.55 % -66.67 % -99.82 % -90.00 % -98.70 %
5Y -85.71 % -97.14 % -80.00 % -100.00 % -100.00 % -99.99 % 0.00 % -99.83 % -91.29 % -99.86 %
10Y -50.00 % -98.67 % -99.00 % -100.00 % -100.00 % -100.00 % -99.90 % -100.00 % -98.31 % -100.00 %
From the beginning -100.00 % -100.00 % -99.96 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend